By Hans Sauer, Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization Question from a Reader...

In the latest Company Snapshot for the 2012 BIO CEO & Investor Conference in New York City, we're profiling ImmunoGen, Inc. wh...

Biotechnology continues to hold the greatest promise to address many of the most critical issues facing our world. Continued inno...

Q&A with ARPA-E Deputy Director for Commercialization Cheryl Martin Q: What is the mission of ARPA-E, and how do you work t...

The 2011 BIO International Convention brought together over 15,000 leaders from industry, government and academia who are working...

Bill Gates has a terse response to criticism that the high-tech solutions he advocates for world hunger are too expensive or bad f...

By Marc Boutin, JD, Executive Vice President and Chief Operating Officer, National Health Council At this time of the year, it...